NCT04614584: Mirtazapine and Methamphetamine Drug-drug Interaction Study |
|
|
| Completed | 1 | 15 | US | Mirtazapine, Methamphetamine | San Francisco Department of Public Health, University of California, Los Angeles | Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities | 05/24 | 05/24 | | |
| Enrolling by invitation | N/A | 200 | US | Opioid Addiction Recovery Support Software Platform, OARS | Q2i, LLC, University of California, Los Angeles, National Institute on Drug Abuse (NIDA) | Opioid-use Disorder | 05/23 | 08/23 | | |
NCT04801758: Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study |
|
|
| Completed | N/A | 18 | RoW | Analytical Treatment Interruption | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), HIV Prevention Trials Network, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | HIV Infection | 07/24 | 07/24 | | |
